1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > EU5 Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

EU5 Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

Summary

GlobalData’s new report, "EU5 Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020", provides key market data on the Europe Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - UFE Procedures using Gelatin Sponge Sheets and UFE Procedures using Polyvinyl Alcohol (PVA) Vials and Tris Acryl Gelatin Microsphere (TAGM) Vials.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

EU5 Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Uterine Fibroid Embolization (UFE) Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Uterine Fibroid Embolization (UFE) Procedures, EU5 5
3.1 Uterine Fibroid Embolization (UFE) Procedures, EU5, 2005-2020 5
3.2 Uterine Fibroid Embolization (UFE) Procedures, EU5, Category Comparison by Procedures, 2005-2020 6
3.3 Uterine Fibroid Embolization (UFE) Procedures, EU5, 2005-2013 7
3.4 Uterine Fibroid Embolization (UFE) Procedures, EU5, 2013-2020 9
4 Uterine Fibroid Embolization (UFE) Procedures, France 11
4.1 Uterine Fibroid Embolization (UFE) Procedures, France, 2005-2013 11
4.2 Uterine Fibroid Embolization (UFE) Procedures, France, 2013-2020 13
5 Uterine Fibroid Embolization (UFE) Procedures, Germany 15
5.1 Uterine Fibroid Embolization (UFE) Procedures, Germany, 2005-2013 15
5.2 Uterine Fibroid Embolization (UFE) Procedures, Germany, 2013-2020 17
6 Uterine Fibroid Embolization (UFE) Procedures, Italy 19
6.1 Uterine Fibroid Embolization (UFE) Procedures, Italy, 2005-2013 19
6.2 Uterine Fibroid Embolization (UFE) Procedures, Italy, 2013-2020 21
7 Uterine Fibroid Embolization (UFE) Procedures, Spain 23
7.1 Uterine Fibroid Embolization (UFE) Procedures, Spain, 2005-2013 23
7.2 Uterine Fibroid Embolization (UFE) Procedures, Spain, 2013-2020 25
8 Uterine Fibroid Embolization (UFE) Procedures, United Kingdom 27
8.1 Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, 2005-2013 27
8.2 Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, 2013-2020 29
9 Appendix 31
9.1 Research Methodology 32
9.1.1 Coverage 32
9.1.2 Secondary Research 32
9.1.3 Primary Research 33
9.1.4 Market Modeling and Forecasting 34
9.1.5 Company Share Analysis 37
9.1.6 Distribution Share Analysis 38
9.2 Expert Panel 38
9.3 GlobalData Consulting 39
9.4 Contact Us 39
9.5 Disclaimer 39

1.1 List of Tables
Table 1: Uterine Fibroid Embolization (UFE) Procedures, EU5, 2005-2020 5
Table 2: Uterine Fibroid Embolization (UFE) Procedures, EU5, Category Comparison by Procedures, 2005-2020 6
Table 3: Uterine Fibroid Embolization (UFE) Procedures, EU5, Historic, 2005-2013 8
Table 4: Uterine Fibroid Embolization (UFE) Procedures, EU5, Forecast, 2013-2020 10
Table 5: Uterine Fibroid Embolization (UFE) Procedures, France, Historic, 2005-2013 12
Table 6: Uterine Fibroid Embolization (UFE) Procedures, France, Forecast, 2013-2020 14
Table 7: Uterine Fibroid Embolization (UFE) Procedures, Germany, Historic, 2005-2013 16
Table 8: Uterine Fibroid Embolization (UFE) Procedures, Germany, Forecast, 2013-2020 18
Table 9: Uterine Fibroid Embolization (UFE) Procedures, Italy, Historic, 2005-2013 20
Table 10: Uterine Fibroid Embolization (UFE) Procedures, Italy, Forecast, 2013-2020 22
Table 11: Uterine Fibroid Embolization (UFE) Procedures, Spain, Historic, 2005-2013 24
Table 12: Uterine Fibroid Embolization (UFE) Procedures, Spain, Forecast, 2013-2020 26
Table 13: Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, Historic, 2005-2013 28
Table 14: Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, Forecast, 2013-2020 30
Table 15: Total Number of Primary Research Participants, General Surgery Market, by Country 34

1.2 List of Figures
Figure 1: Uterine Fibroid Embolization (UFE) Procedures, EU5, 2005-2020 5
Figure 2: Uterine Fibroid Embolization (UFE) Procedures, EU5, Category Comparison by Procedures, 2005-2020 6
Figure 3: Uterine Fibroid Embolization (UFE) Procedures, EU5, Historic, 2005-2013 7
Figure 4: Uterine Fibroid Embolization (UFE) Procedures, EU5, Forecast, 2013-2020 9
Figure 5: Uterine Fibroid Embolization (UFE) Procedures, France, Historic, 2005-2013 11
Figure 6: Uterine Fibroid Embolization (UFE) Procedures, France, Forecast, 2013-2020 13
Figure 7: Uterine Fibroid Embolization (UFE) Procedures, Germany, Historic, 2005-2013 15
Figure 8: Uterine Fibroid Embolization (UFE) Procedures, Germany, Forecast, 2013-2020 17
Figure 9: Uterine Fibroid Embolization (UFE) Procedures, Italy, Historic, 2005-2013 19
Figure 10: Uterine Fibroid Embolization (UFE) Procedures, Italy, Forecast, 2013-2020 21
Figure 11: Uterine Fibroid Embolization (UFE) Procedures, Spain, Historic, 2005-2013 23
Figure 12: Uterine Fibroid Embolization (UFE) Procedures, Spain, Forecast, 2013-2020 25
Figure 13: Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, Historic, 2005-2013 27
Figure 14: Uterine Fibroid Embolization (UFE) Procedures, United Kingdom, Forecast, 2013-2020 29
Figure 15: GlobalData Epidemiology-Based Forecasting Model 36
Figure 16: GlobalData Capital Equipment-Based Forecasting Model 37
Figure 17: Primary Interviews by Participant Type (%) 38

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.